ClinicalTrials.Veeva

Menu

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding (HALT)

Cook Group logo

Cook Group

Status

Completed

Conditions

Bleeding Peptic Ulcers

Treatments

Device: Hemospray Kit

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The objective of this study is to show that Hemospray is effective in achieving initial hemostasis and documenting rate of further bleed when compared to standard of care.

Enrollment

67 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Bleeding peptic ulcer

Exclusion criteria

  • Patient is: < 18 years of age
  • Patient is unable to consent
  • Patient is contraindicated to undergo endoscopy
  • Patient has: coagulopathy, altered post surgical anatomy of the stomach, previously placed intrahepatic portosystemic shunt
  • Patient is pregnant or lactating
  • Patinet has an INR > 2.5

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

67 participants in 1 patient group

Hemospray Treatment
Experimental group
Description:
Hemospray Kit
Treatment:
Device: Hemospray Kit

Trial contacts and locations

12

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems